rs187172641
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001123385.2(BCOR):āc.3974A>Gā(p.Lys1325Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000293 in 1,200,919 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 99 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001123385.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCOR | NM_001123385.2 | c.3974A>G | p.Lys1325Arg | missense_variant | 9/15 | ENST00000378444.9 | NP_001116857.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCOR | ENST00000378444.9 | c.3974A>G | p.Lys1325Arg | missense_variant | 9/15 | 1 | NM_001123385.2 | ENSP00000367705 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000267 AC: 30AN: 112314Hom.: 0 Cov.: 22 AF XY: 0.000174 AC XY: 6AN XY: 34494
GnomAD3 exomes AF: 0.00162 AC: 262AN: 162094Hom.: 0 AF XY: 0.00124 AC XY: 63AN XY: 50986
GnomAD4 exome AF: 0.000297 AC: 323AN: 1088551Hom.: 0 Cov.: 32 AF XY: 0.000262 AC XY: 93AN XY: 355521
GnomAD4 genome AF: 0.000258 AC: 29AN: 112368Hom.: 0 Cov.: 22 AF XY: 0.000174 AC XY: 6AN XY: 34558
ClinVar
Submissions by phenotype
not specified Benign:1Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jan 05, 2016 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2021 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Oculofaciocardiodental syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 18, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at